CCL2 and migraine disorder: Protein measurements in cerebrospinal fluid (CSF) showed that transforming growth factor-β (TGF-β), IL-1β receptor antagonist, and monocyte chemoattractant protein-1 levels were significantly different in migraine patients compared to controls20.